4D Molecular Therapeutics Inc
NASDAQ:FDMT
4D Molecular Therapeutics Inc
NASDAQ:FDMT
Price:
9.84
USD
3.8%
Market Cap:
$501.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
2
|
2G Energy AG
XETRA:2GB
|
DE |
|
Tsumura & Co
TSE:4540
|
JP |
Cash Flow Statement
Cash Flow Statement
4D Molecular Therapeutics Inc
4D Molecular Therapeutics Inc
Currency: USD
| Sep-2019 | Dec-2019 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||
| Net Income |
(38)
|
(49)
|
(52)
|
(57)
|
(73)
|
(81)
|
(67)
|
(71)
|
(81)
|
(102)
|
(105)
|
(107)
|
(110)
|
(111)
|
(96)
|
(101)
|
(105)
|
(110)
|
(143)
|
(161)
|
(176)
|
(196)
|
(209)
|
(140)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
4
|
4
|
4
|
4
|
4
|
6
|
5
|
5
|
5
|
3
|
5
|
|
| Stock-Based Compensation |
2
|
4
|
6
|
5
|
7
|
11
|
12
|
14
|
15
|
16
|
17
|
17
|
17
|
18
|
18
|
20
|
21
|
23
|
24
|
26
|
27
|
26
|
24
|
22
|
|
| Other Non-Cash Items |
9
|
11
|
7
|
5
|
8
|
11
|
12
|
16
|
19
|
20
|
21
|
20
|
19
|
19
|
19
|
20
|
22
|
21
|
19
|
21
|
22
|
22
|
23
|
20
|
|
| Change in Working Capital |
(10)
|
0
|
2
|
(1)
|
(3)
|
(15)
|
(12)
|
(16)
|
(16)
|
(1)
|
(4)
|
(1)
|
(3)
|
(4)
|
(0)
|
1
|
2
|
(0)
|
5
|
1
|
(3)
|
3
|
(0)
|
6
|
|
| Cash from Operating Activities |
(38)
N/A
|
(37)
+3%
|
(42)
-15%
|
(51)
-21%
|
(66)
-30%
|
(82)
-24%
|
(65)
+21%
|
(69)
-7%
|
(77)
-12%
|
(81)
-5%
|
(86)
-7%
|
(87)
0%
|
(91)
-5%
|
(93)
-2%
|
(73)
+21%
|
(76)
-3%
|
(77)
-2%
|
(85)
-11%
|
(113)
-33%
|
(135)
-19%
|
(153)
-14%
|
(166)
-9%
|
(183)
-10%
|
(109)
+41%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||
| Capital Expenditures |
(3)
|
(3)
|
(1)
|
(1)
|
(2)
|
(2)
|
(5)
|
(9)
|
(15)
|
(16)
|
(16)
|
(12)
|
(6)
|
(5)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(2)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
(136)
|
(164)
|
(211)
|
(152)
|
2
|
(6)
|
86
|
77
|
90
|
118
|
(188)
|
(311)
|
(313)
|
(299)
|
(4)
|
56
|
44
|
(92)
|
|
| Cash from Investing Activities |
(3)
N/A
|
(3)
-3%
|
(1)
+70%
|
(1)
-4%
|
(2)
-64%
|
(2)
-45%
|
(141)
-5 820%
|
(173)
-23%
|
(226)
-31%
|
(168)
+26%
|
(14)
+92%
|
(17)
-26%
|
80
N/A
|
72
-10%
|
87
+20%
|
116
+34%
|
(191)
N/A
|
(314)
-64%
|
(316)
-1%
|
(302)
+4%
|
(7)
+98%
|
52
N/A
|
43
-18%
|
(93)
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||||||
| Net Issuance of Common Stock |
85
|
0
|
73
|
279
|
279
|
280
|
209
|
118
|
119
|
118
|
116
|
4
|
14
|
145
|
155
|
157
|
465
|
351
|
341
|
337
|
0
|
2
|
2
|
113
|
|
| Other |
(2)
|
(2)
|
(1)
|
0
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(1)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
83
N/A
|
(2)
N/A
|
72
N/A
|
279
+286%
|
278
0%
|
279
+0%
|
208
-25%
|
118
-43%
|
120
+1%
|
119
-1%
|
117
-1%
|
3
-97%
|
13
+335%
|
144
+971%
|
154
+7%
|
157
+2%
|
465
+196%
|
351
-24%
|
341
-3%
|
337
-1%
|
0
N/A
|
2
N/A
|
2
-22%
|
113
+7 054%
|
|
| Change in Cash | |||||||||||||||||||||||||
| Net Change in Cash |
42
N/A
|
(42)
N/A
|
29
N/A
|
227
+675%
|
210
-7%
|
194
-8%
|
2
-99%
|
(124)
N/A
|
(184)
-49%
|
(130)
+29%
|
17
N/A
|
(101)
N/A
|
3
N/A
|
123
+4 642%
|
167
+36%
|
197
+18%
|
197
+0%
|
(47)
N/A
|
(88)
-87%
|
(100)
-13%
|
(142)
-42%
|
(112)
+21%
|
(139)
-24%
|
(89)
+36%
|
|
| Free Cash Flow | |||||||||||||||||||||||||
| Free Cash Flow |
(41)
N/A
|
(40)
+3%
|
(43)
-8%
|
(52)
-21%
|
(68)
-31%
|
(85)
-25%
|
(69)
+18%
|
(78)
-13%
|
(92)
-18%
|
(97)
-5%
|
(102)
-5%
|
(98)
+4%
|
(97)
+1%
|
(98)
-1%
|
(77)
+22%
|
(79)
-2%
|
(79)
-1%
|
(87)
-10%
|
(117)
-34%
|
(138)
-19%
|
(157)
-13%
|
(170)
-8%
|
(185)
-9%
|
(110)
+41%
|
|
Switch to:
Switch to:
See Also
Discover More
